Comparison of PGS2.0 versus conventional embryo morphology evaluation for patients with recurrent pregnancy loss: a study protocol for a multicentre randomised trial. Issue 10 (7th October 2020)

• Record Type: Journal Article
• Authors: Lei, Caixia; Sui, Yilun; Ye, Jiangfeng; Lu, Yao; Xi, Ji; Sun, Yun; Jin, Li; Sun, Xiaoxi
• Is Part Of: BMJ open. Volume 10:Issue 10(2020)
• Publication Date: 2020-10-07
• Subjects: prenatal diagnosis -- reproductive medicine -- antenatal; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2019-036252
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: Pregnancy loss (PL) is an adverse life event, and there is no proven effective treatment for recurrent PL (RPL). Preimplantation genetic screening (PGS) can be performed to reduce the risks of PL; however, there is still no solid scientific evidence that PGS improves outcomes for couples experiencing RPL. Comprehensive chromosome screening (PGS2.0) has become a routine practice in in vitro fertilisation (IVF) clinics. Previous studies based on PGS1.0 with a focus on RPL couples where the female is of advanced maternal age have reported contradictory results. Hence, a multicentre randomised trial is needed to provide evidence for the clinical benefits of PGS2.0 treatment for RPL couples. Methods and analysis: Overall, 268 RPL couples undergoing IVF cycles will be enrolled. Couples will be randomised according to a unique grouping number generated by a random digital software into (1) PGS2.0 group and (2) non-PGS (conventional embryo morphology evaluation) group. This study aims to investigate whether the live birth rate (LBR) per initiated cycle after PGS2.0 is superior to the LBR per initiated cycle after conventional embryo evaluation (non-PGS group). Live birth will be defined as a live baby born after a gestation period of >28 weeks, with a birth weight of more than 1000 g. A multivariate logistic regression model will be used to adjust for confounding factors. Ethics and dissemination: Ethical approval has been granted by the Ethics Committee of Obstetrics and Gynecology Hospital, Fudan University and the participating hospitals. Written informed consent will be obtained from each couple before any study procedure is performed. Data from this study will be stored in the Research Electronic Data Capture. The results of this trial will be presented and published via peer-reviewed publications and presentations at international conferences. Trial registration number: NCT03214185 ; Pre-results.